The evolution of durvalumab in NSCLC care
Hospital Pharmacy Europe
NOVEMBER 4, 2024
This could include educational initiatives such as workshops, seminars and webinars focused on the role of durvalumab in non-small cell lung cancers. We can see at a microscopic level whether the treatment is working or not, so that we can make clinical management decisions more quickly than we have done historically.’
52 
Let's personalize your content